Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone: an open-label, randomized, parallel-group study

BACKGROUND: This exploratory study compared the inhibition of bone erosion progression in rheumatoid arthritis (RA) patients treated with a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab versus csDMARD therapy alone and investigated the effects of denosumab on...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Naoki, Chiba, Ko, Sato, Shuntaro, Shiraishi, Kazuteru, Watanabe, Kounosuke, Oki, Nozomi, Okada, Akitomo, Koga, Tomohiro, Kawashiri, Shin-ya, Tamai, Mami, Hosogaya, Naoki, Furuyama, Masako, Kobayashi, Makiko, Saito, Kengo, Okubo, Naoki, Uetani, Masataka, Osaki, Makoto, Kawakami, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727996/
https://www.ncbi.nlm.nih.gov/pubmed/36476479
http://dx.doi.org/10.1186/s13075-022-02957-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727996/
https://www.ncbi.nlm.nih.gov/pubmed/36476479
http://dx.doi.org/10.1186/s13075-022-02957-w

Ejemplares similares